Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Pharmacovigilance Study of Post-vaccine Adverse Events of Sinovac's/ Butantan Institute Adsorbed COVID-19 (Inactivated) Vaccine

NCT04845048 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT04845048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04845048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Pharmacovigilance Study of Post-vaccine Adverse Events of Sinovac's/ Butantan Institute Adsorbed COVID-19 (Inactivated) Vaccine
Lead sponsor
Butantan Institute
Phase
Observational
Overall status
Completed
Start date
May 10, 2021
Completion date
March 13, 2023
Enrollment
2,549 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 acute respiratory disease